Immunosciences Lab, Inc.

Immunosciences Lab is a clinical reference and research laboratory in the field of molecular medicine. ISL utilizes highly sensitive and accurate testing methods for detecting Lyme disease, autoimmunity, and viral infections. They have demonstrated the ability to identify more than 80 autoimmune diseases to date.

Immunosciences Lab, Inc. considers its patented, researched methods to be most sensitive in detecting the antibodies against Lyme and certain tick-borne disease (Babesia, Ehrlichia, and Bartonella).

About Immunosciences Lab

Immunosciences Lab, Inc. was initiated in 1989 as a pioneer laboratory in clinical immunology and is currently located in Los Angeles, California. They strive for better diagnostic testing to facilitate early detection of compromise in complex diseases and improve diagnosis and management of patient health.

Immunosciences Lab, Inc. implements diagnostic tests and testing methods supported by scientific research and knowledge focusing on preventive medicine, microbiology, clinical immunology, and environmental triggers in illness.

Immunosciences Labs specializes in a range of diagnostic panels designed to address complex medical conditions:

Autoimmunity Panels 

These panels target over 80 identified autoimmune diseases. Autoimmune conditions often have overlapping symptoms, making accurate diagnosis challenging and typically delayed until symptoms worsen significantly.

Lyme Disease Panels 

Diagnosing Lyme disease is complicated due to symptom overlap with conditions like Alzheimer’s, autism, chronic fatigue syndrome, fibromyalgia, and others. The lab combines clinical symptoms with advanced diagnostic techniques to ensure accurate detection.

Viral Infection Panels

Focused on identifying the role of viruses such as HHV-6 in autoimmunity, these panels explore how viruses can impair T-cell functions and potentially over-activate the immune system, emphasizing the importance of timely and accurate diagnosis.

Autoimmune Viral Trio Panel

The Autoimmune Viral Trio Panel ocuses on the intersection of viral infections and autoimmune responses. It specifically examines how certain viruses, known to influence immune function, can trigger autoimmune diseases. These include:

• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): the COVID virus can provoke varied immune responses, potentially leading to autoimmune conditions. 

• Epstein-Barr Virus (EBV): Almost universally acquired, EBV is linked to numerous autoimmune and proliferative disorders, such as rheumatoid arthritis and multiple sclerosis. 

• Human Herpesvirus 6 (HHV-6): a common early childhood infection, HHV-6 persists in various body cells and can reactivate, particularly influencing conditions like chronic fatigue syndrome and multiple sclerosis. 

Founder of Immunosciences Lab

Immunosciences Lab was founded by Dr. Aristo Vojdani, a respected academic and researcher, Immunosciences Lab.  

Dr. Vojdani holds positions as a Clinical Professor in the Department of Preventive Medicine at Loma Linda University, an Adjunct Professor at the National University of Health Sciences, and has past affiliations with Charles Drew/UCLA School of Medicine and Science. 

His academic journey includes an MSc and PhD in microbiology and clinical immunology from Bar-Ilan University in Israel, with further postdoctoral studies in immunology at UCLA.

Dr. Vojdani's career, spanning over 45 years, focuses on the impact of environmental triggers on complex diseases. He has developed over 300 antibody assays to detect autoimmune diseases and other conditions, particularly those that link the gut to systemic and neurological disorders. 

Dr. Vojdani holds 17 U.S. patents related to immune dysfunctions associated with the gut and brain, and he has contributed to over 200 scientific publications. His authored books include "Neuroimmunity and the Brain-Gut Connection" and "Food-Associated Autoimmunities: When Food Breaks Your Immune System."

Dr. Vojdani is currently serving as CEO and Technical Director of Immunosciences Lab in Los Angeles.

Certifications and Licenses

Immunoscience Lab., Inc., is CLIA-Certified, CAP-Accredited, and California-Licensed. 

References

[1.] Bjornevik K, Münz C, Cohen JI, Ascherio A. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nature Reviews Neurology. 2023;19(3):160-171. Doi: https://www.nature.com/articles/s41582-023-00775-5

[2.] Chen X, Wang C, Chen SZ, Tian M, Wang X, Zhang L. Fulminant Type 1 Diabetes Mellitus Associated With Drug Hypersensitivity and Epstein–Barr Virus Infection: A Case Report. Frontiers in Pharmacology. 2022;13. Doi: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.884878/full

[3.] Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol. 2021 Jan 7;11:587380. doi: 10.3389/fimmu.2020.587380. PMID: 33488588; PMCID: PMC7817975. 

[4.] Nissen LHC, Nagtegaal ID, Dirk, et al. Epstein–Barr Virus in Inflammatory Bowel Disease: The Spectrum of Intestinal Lymphoproliferative Disorders. 2015;9(5):398-403. Doi: https://academic.oup.com/ecco-jcc/article/9/5/398/408893

[5.] Toussirot É, Roudier J. Epstein–Barr virus in autoimmune diseases. Best Practice & Research Clinical Rheumatology. 2008;22(5):883-896. Doi: https://www.sciencedirect.com/science/article/abs/pii/S1521694208001046?via%3Dihub‌

[6.] Welch NL, Welch T, Songtanin B. Viral Triggered Celiac Disease: A Case Report. Cureus. 2023 Jun 14;15(6):e40429. doi: 10.7759/cureus.40429. PMID: 37456501; PMCID: PMC10348803.